NOVEL TYPE-1 CYTOKINE RECEPTOR GLM-R
    52.
    发明申请
    NOVEL TYPE-1 CYTOKINE RECEPTOR GLM-R 审中-公开
    新型1型细胞因子受体GLM-R

    公开(公告)号:US20070136829A1

    公开(公告)日:2007-06-14

    申请号:US11548639

    申请日:2006-10-11

    CPC分类号: C07K14/7158

    摘要: The present invention is directed to novel polypeptides and variants thereof of GLM-R polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Also provided are methods for detecting agents that modulate the activity of GLM-R. Also provided are methods for diagnosing and for treating disorders characterized by the over or under abundance of monocytes or macrophages.

    摘要翻译: 本发明涉及GLM-R多肽的新型多肽及其变体以及编码这些多肽的核酸分子。 本文还提供了包含那些核酸序列的载体和宿主细胞,包含与异源多肽序列融合的本发明的多肽的嵌合多肽分子,与本发明的多肽结合的抗体以及本发明的多肽的制备方法 发明。 还提供了用于检测调节GLM-R的活性的试剂的方法。 还提供了用于诊断和治疗特征在于单核细胞或巨噬细胞过度或不丰富的疾病的方法。

    Method of Diagnosing and Treating Cartilaginous Disorders
    54.
    发明申请
    Method of Diagnosing and Treating Cartilaginous Disorders 审中-公开
    诊断和治疗软骨疾病的方法

    公开(公告)号:US20070160594A1

    公开(公告)日:2007-07-12

    申请号:US11612263

    申请日:2006-12-18

    摘要: The present invention is directed to novel polypeptides having sequence similarity to human inter-alpha-trypsin inhibitor and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods of using the polypeptide to diagnose and treat damage to cartilage resulting from injury and/or cartilaginous disorders.

    摘要翻译: 本发明涉及与人α间胰蛋白酶抑制剂和编码这些多肽的核酸分子具有序列相似性的新型多肽。 本文还提供了包含那些核酸序列的载体和宿主细胞,包含与异源多肽序列融合的本发明的多肽的嵌合多肽分子,与本发明的多肽结合的抗体以及本发明的多肽的制备方法 发明。 本文还提供了使用多肽来诊断和治疗由损伤和/或软骨障碍引起的软骨损伤的方法。

    Novel polypeptides having sequence similarity to GDNFR and nucleic acids encoding the same
    57.
    发明申请
    Novel polypeptides having sequence similarity to GDNFR and nucleic acids encoding the same 有权
    与GDNFR具有序列相似性的新型多肽和编码其的核酸

    公开(公告)号:US20070154475A1

    公开(公告)日:2007-07-05

    申请号:US11709185

    申请日:2007-02-20

    CPC分类号: A61K39/395

    摘要: The present invention is directed to novel polypeptides having sequence similarity to GDNFR and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

    摘要翻译: 本发明涉及与GDNFR具有序列相似性的新型多肽和编码那些多肽的核酸分子。 本文还提供了包含那些核酸序列的载体和宿主细胞,包含与异源多肽序列融合的本发明的多肽的嵌合多肽分子,与本发明的多肽结合的抗体以及本发明的多肽的制备方法 发明。